These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8521180

  • 1. Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes.
    Tenor H, Staniciu L, Schudt C, Hatzelmann A, Wendel A, Djukanović R, Church MK, Shute JK.
    Clin Exp Allergy; 1995 Jul; 25(7):616-24. PubMed ID: 8521180
    [Abstract] [Full Text] [Related]

  • 2. Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages.
    Tenor H, Hatzelmann A, Kupferschmidt R, Stanciu L, Djukanović R, Schudt C, Wendel A, Church MK, Shute JK.
    Clin Exp Allergy; 1995 Jul; 25(7):625-33. PubMed ID: 8521181
    [Abstract] [Full Text] [Related]

  • 3. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ, Cieslinski LB.
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [Abstract] [Full Text] [Related]

  • 4. Isoenzyme-selective cyclic nucleotide phosphodiesterase inhibitors: effects on airways smooth muscle.
    Raeburn D, Advenier C.
    Int J Biochem Cell Biol; 1995 Jan; 27(1):29-37. PubMed ID: 7757880
    [Abstract] [Full Text] [Related]

  • 5. Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects.
    Landells LJ, Szilagy CM, Jones NA, Banner KH, Allen JM, Doherty A, O'Connor BJ, Spina D, Page CP.
    Br J Pharmacol; 2001 Jul; 133(5):722-9. PubMed ID: 11429397
    [Abstract] [Full Text] [Related]

  • 6. Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes.
    Robicsek SA, Blanchard DK, Djeu JY, Krzanowski JJ, Szentivanyi A, Polson JB.
    Biochem Pharmacol; 1991 Jul 25; 42(4):869-77. PubMed ID: 1651080
    [Abstract] [Full Text] [Related]

  • 7. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
    Jones NA, Leport M, Holand T, Vos T, Morgan M, Fink M, Pruniaux MP, Berthelier C, O'Connor BJ, Bertrand C, Page CP.
    Pulm Pharmacol Ther; 2007 Jul 25; 20(1):60-8. PubMed ID: 16427796
    [Abstract] [Full Text] [Related]

  • 8. Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study.
    Gantner F, Tenor H, Gekeler V, Schudt C, Wendel A, Hatzelmann A.
    J Allergy Clin Immunol; 1997 Oct 25; 100(4):527-35. PubMed ID: 9338548
    [Abstract] [Full Text] [Related]

  • 9. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
    Turner NC, Wood LJ, Burns FM, Gueremy T, Souness JE.
    Br J Pharmacol; 1993 Apr 25; 108(4):876-83. PubMed ID: 8387385
    [Abstract] [Full Text] [Related]

  • 10. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Ichimura M, Eiki R, Osawa K, Nakanishi S, Kase H.
    Biochem J; 1996 May 15; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
    [Abstract] [Full Text] [Related]

  • 11. Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2.
    Giembycz MA, Corrigan CJ, Seybold J, Newton R, Barnes PJ.
    Br J Pharmacol; 1996 Aug 15; 118(8):1945-58. PubMed ID: 8864528
    [Abstract] [Full Text] [Related]

  • 12. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE, Lakey T, Houslay MD.
    Biochem Pharmacol; 1989 Nov 15; 38(22):4123-36. PubMed ID: 2480793
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.
    de Cheffoy de Courcelles D, de Loore K, Freyne E, Janssen PA.
    J Pharmacol Exp Ther; 1992 Oct 15; 263(1):6-14. PubMed ID: 1328613
    [Abstract] [Full Text] [Related]

  • 14. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C, Schini VB.
    Biochem Pharmacol; 1990 Jan 01; 39(1):75-84. PubMed ID: 2153383
    [Abstract] [Full Text] [Related]

  • 15. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A, Ono K, Sato Y, Shioi T, Nose Y, Sasayama S.
    J Mol Cell Cardiol; 1996 Dec 01; 28(12):2491-9. PubMed ID: 9004165
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes.
    Aleksijevic A, Lugnier C, Giron C, Mayer S, Stoclet JC, Lang JM.
    Int J Immunopharmacol; 1987 Dec 01; 9(5):525-31. PubMed ID: 3040609
    [Abstract] [Full Text] [Related]

  • 18. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE, Diocee BK, Martin W, Moodie SA.
    Biochem J; 1990 Feb 15; 266(1):127-32. PubMed ID: 2155604
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells.
    Whalen MM, Crews JD.
    Biochem Pharmacol; 2000 Aug 15; 60(4):499-506. PubMed ID: 10874124
    [Abstract] [Full Text] [Related]

  • 20. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC, Uckert S, Stief CG, Schulz-Knappe P, Hess R, Forssmann WG, Jonas U.
    Urology; 1995 May 15; 45(5):893-901. PubMed ID: 7747383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.